Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors

Madhavika N. Serasinghe, Shira Y. Wieder, Thibaud T. Renault, Rana Elkholi, James J. Asciolla, Jonathon L. Yao, Omar Jabado, Kyle Hoehn, Yusuke Kageyama, Hiromi Sesaki, Jerry E. Chipuk

Research output: Contribution to journalArticle

Abstract

Mitochondrial division is essential for mitosis and metazoan development, but a mechanistic role in cancer biology remains unknown. Here, we examine the direct effects of oncogenic RASG12V-mediated cellular transformation on the mitochondrial dynamics machinery and observe a positive selection for dynamin-related protein 1 (DRP1), a protein required for mitochondrial network division. Loss ofDRP1 prevents RASG12V-induced mitochondrial dysfunction and renders cells resistant to transformation. Conversely, in human tumor cell lines with activating MAPK mutations, inhibition of these signals leads to robust mitochondrial network reprogramming initiated by DRP1 loss resulting in mitochondrial hyper-fusion and increased mitochondrial metabolism. These phenotypes are mechanistically linked by ERK1/2 phosphorylation of DRP1 serine 616; DRP1S616 phosphorylation is sufficient to phenocopy transformation-induced mitochondrial dysfunction, and DRP1S616 phosphorylation status dichotomizes BRAFWT from BRAFV600E-positive lesions. These findings implicate mitochondrial division and DRP1 as crucial regulators of transformation with leverage in chemotherapeutic success.

Original languageEnglish (US)
Pages (from-to)521-537
Number of pages17
JournalMolecular Cell
Volume57
Issue number3
DOIs
StatePublished - Feb 5 2015

Fingerprint

Dynamins
Mitochondrial Dynamics
Phosphorylation
Proteins
Dynamin II
Mitochondrial Proteins
Tumor Cell Line
Mitosis
Serine
Phenotype
Mutation
Neoplasms

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Serasinghe, M. N., Wieder, S. Y., Renault, T. T., Elkholi, R., Asciolla, J. J., Yao, J. L., ... Chipuk, J. E. (2015). Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors. Molecular Cell, 57(3), 521-537. https://doi.org/10.1016/j.molcel.2015.01.003

Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors. / Serasinghe, Madhavika N.; Wieder, Shira Y.; Renault, Thibaud T.; Elkholi, Rana; Asciolla, James J.; Yao, Jonathon L.; Jabado, Omar; Hoehn, Kyle; Kageyama, Yusuke; Sesaki, Hiromi; Chipuk, Jerry E.

In: Molecular Cell, Vol. 57, No. 3, 05.02.2015, p. 521-537.

Research output: Contribution to journalArticle

Serasinghe, MN, Wieder, SY, Renault, TT, Elkholi, R, Asciolla, JJ, Yao, JL, Jabado, O, Hoehn, K, Kageyama, Y, Sesaki, H & Chipuk, JE 2015, 'Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors', Molecular Cell, vol. 57, no. 3, pp. 521-537. https://doi.org/10.1016/j.molcel.2015.01.003
Serasinghe, Madhavika N. ; Wieder, Shira Y. ; Renault, Thibaud T. ; Elkholi, Rana ; Asciolla, James J. ; Yao, Jonathon L. ; Jabado, Omar ; Hoehn, Kyle ; Kageyama, Yusuke ; Sesaki, Hiromi ; Chipuk, Jerry E. / Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors. In: Molecular Cell. 2015 ; Vol. 57, No. 3. pp. 521-537.
@article{cab39a8633664d1b9962bf4de66589f4,
title = "Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors",
abstract = "Mitochondrial division is essential for mitosis and metazoan development, but a mechanistic role in cancer biology remains unknown. Here, we examine the direct effects of oncogenic RASG12V-mediated cellular transformation on the mitochondrial dynamics machinery and observe a positive selection for dynamin-related protein 1 (DRP1), a protein required for mitochondrial network division. Loss ofDRP1 prevents RASG12V-induced mitochondrial dysfunction and renders cells resistant to transformation. Conversely, in human tumor cell lines with activating MAPK mutations, inhibition of these signals leads to robust mitochondrial network reprogramming initiated by DRP1 loss resulting in mitochondrial hyper-fusion and increased mitochondrial metabolism. These phenotypes are mechanistically linked by ERK1/2 phosphorylation of DRP1 serine 616; DRP1S616 phosphorylation is sufficient to phenocopy transformation-induced mitochondrial dysfunction, and DRP1S616 phosphorylation status dichotomizes BRAFWT from BRAFV600E-positive lesions. These findings implicate mitochondrial division and DRP1 as crucial regulators of transformation with leverage in chemotherapeutic success.",
author = "Serasinghe, {Madhavika N.} and Wieder, {Shira Y.} and Renault, {Thibaud T.} and Rana Elkholi and Asciolla, {James J.} and Yao, {Jonathon L.} and Omar Jabado and Kyle Hoehn and Yusuke Kageyama and Hiromi Sesaki and Chipuk, {Jerry E.}",
year = "2015",
month = "2",
day = "5",
doi = "10.1016/j.molcel.2015.01.003",
language = "English (US)",
volume = "57",
pages = "521--537",
journal = "Molecular Cell",
issn = "1097-2765",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors

AU - Serasinghe, Madhavika N.

AU - Wieder, Shira Y.

AU - Renault, Thibaud T.

AU - Elkholi, Rana

AU - Asciolla, James J.

AU - Yao, Jonathon L.

AU - Jabado, Omar

AU - Hoehn, Kyle

AU - Kageyama, Yusuke

AU - Sesaki, Hiromi

AU - Chipuk, Jerry E.

PY - 2015/2/5

Y1 - 2015/2/5

N2 - Mitochondrial division is essential for mitosis and metazoan development, but a mechanistic role in cancer biology remains unknown. Here, we examine the direct effects of oncogenic RASG12V-mediated cellular transformation on the mitochondrial dynamics machinery and observe a positive selection for dynamin-related protein 1 (DRP1), a protein required for mitochondrial network division. Loss ofDRP1 prevents RASG12V-induced mitochondrial dysfunction and renders cells resistant to transformation. Conversely, in human tumor cell lines with activating MAPK mutations, inhibition of these signals leads to robust mitochondrial network reprogramming initiated by DRP1 loss resulting in mitochondrial hyper-fusion and increased mitochondrial metabolism. These phenotypes are mechanistically linked by ERK1/2 phosphorylation of DRP1 serine 616; DRP1S616 phosphorylation is sufficient to phenocopy transformation-induced mitochondrial dysfunction, and DRP1S616 phosphorylation status dichotomizes BRAFWT from BRAFV600E-positive lesions. These findings implicate mitochondrial division and DRP1 as crucial regulators of transformation with leverage in chemotherapeutic success.

AB - Mitochondrial division is essential for mitosis and metazoan development, but a mechanistic role in cancer biology remains unknown. Here, we examine the direct effects of oncogenic RASG12V-mediated cellular transformation on the mitochondrial dynamics machinery and observe a positive selection for dynamin-related protein 1 (DRP1), a protein required for mitochondrial network division. Loss ofDRP1 prevents RASG12V-induced mitochondrial dysfunction and renders cells resistant to transformation. Conversely, in human tumor cell lines with activating MAPK mutations, inhibition of these signals leads to robust mitochondrial network reprogramming initiated by DRP1 loss resulting in mitochondrial hyper-fusion and increased mitochondrial metabolism. These phenotypes are mechanistically linked by ERK1/2 phosphorylation of DRP1 serine 616; DRP1S616 phosphorylation is sufficient to phenocopy transformation-induced mitochondrial dysfunction, and DRP1S616 phosphorylation status dichotomizes BRAFWT from BRAFV600E-positive lesions. These findings implicate mitochondrial division and DRP1 as crucial regulators of transformation with leverage in chemotherapeutic success.

UR - http://www.scopus.com/inward/record.url?scp=84924768387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924768387&partnerID=8YFLogxK

U2 - 10.1016/j.molcel.2015.01.003

DO - 10.1016/j.molcel.2015.01.003

M3 - Article

C2 - 25658204

AN - SCOPUS:84924768387

VL - 57

SP - 521

EP - 537

JO - Molecular Cell

JF - Molecular Cell

SN - 1097-2765

IS - 3

ER -